We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GFT505 Reduces the Risk of Cardiovascular Events

News   May 17, 2013

 
GFT505 Reduces the Risk of Cardiovascular Events
 
 
 

RELATED ARTICLES

Compound Combo Shrinks Pancreatic Tumors in Mice Providing Rationale for Clinical Study

News

Scientists have identified a combination of two anti-cancer compounds that were able to shrink pancreatic tumors in mice – supporting the immediate evaluation of the drugs in a clinical trial.

READ MORE

Screening System Designed To Detect Drugs That Block Drivers of Cancer Cell Growth

News

A new screening system leverages redundancy in an important component of a cell – nucleotide metabolism – to help detect new drugs that specifically and potently block processes that are essential for cancer cell growth.

READ MORE

Blood Test Could Reveal High Risk Heart Patients in Need of Treatment

News

Without occasionally looking under the hood, it’s difficult to predict whether expensive car repairs lie ahead. In a similar way, preventive cardiologists are looking for ways to detect early stage heart disease in people who aren’t currently in treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE